Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

4.221

+0.081 (1.97%)

Aug 21, 2026, 2:50 PM EDT - Market open

Ironwood Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	389.32	296.15	351.41	442.74	410.6	413.75
Revenue Growth	26.19%	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Gross Profit	300.62	201.02	239.99	337.95	366.33	343.35
Operating Income	236.27	118.95	96.36	195.84	250.34	232.22
Net Income	129.87	24.02	0.88	-1,002	175.07	528.45
Earnings Per Share	0.79	0.15	0.01	-6.45	0.96	3.21
EPS Growth	-	2583.01%	-	-	-69.98%	386.36%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	289.34	341.22	432.99	402.79	404.65
Rest of World	6.81	10.19	9.74	7.8	9.1
Total	296.15	351.41	442.74	410.6	413.75

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	79.13	215.46	88.56	92.15	656.2	620.13
Total Debt	396.87	597.8	599.48	715.54	415.92	475.8
Net Cash (Debt)	-317.74	-382.35	-510.92	-623.38	240.29	144.33
Net Cash Growth	-	-	-	-	66.49%	-
Net Cash Per Share	-1.92	-2.35	-3.19	-4.01	1.29	0.88

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	185.56	127.04	103.55	183.43	273.76	261.9
Capital Expenditures	-0	-0.03	-0.14	-0.27	-0.14	-0.27
Free Cash Flow	185.55	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Growth	519.84%	22.82%	-43.54%	-33.06%	4.58%	56.67%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	77.22%	67.88%	68.29%	76.33%	89.22%	82.98%
Operating Margin	60.69%	40.17%	27.42%	44.23%	60.97%	56.12%
Pretax Margin	53.27%	23.65%	18.55%	-214.14%	61.48%	48.50%
Profit Margin	33.36%	8.11%	0.25%	-226.37%	42.64%	127.72%
FCF Margin	47.66%	42.89%	29.43%	41.37%	66.64%	63.23%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.36	22.83	805.60	-	10.86	3.61
Forward PE	3.37	7.84	13.42	14.14	11.24	8.43
P/FCF Ratio	3.80	4.32	6.86	9.75	6.95	7.29
PS Ratio	1.81	1.85	2.02	4.03	4.63	4.61